Rare diseases
Investigational molecules
Locations
Back to Ireland159 clinical trials in Cork, Ireland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
IrelandStudy of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients
IrelandStudy on the Safety and Effectiveness of Tafasitamab and Lenalidomide for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
IrelandStudy of Giredestrant, Triptorelin, and Anastrozole in Premenopausal Women with ER-Positive/HER2-Negative Early Breast Cancer
IrelandStudy of Trastuzumab Deruxtecan for Patients with Unresectable or Metastatic HER2-low or HER2 IHC0 Breast Cancer
IrelandStudy Comparing Pembrolizumab and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer
IrelandStudy of Pembrolizumab and Enzalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer
IrelandStudy of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment
IrelandStudy on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19
IrelandStudy on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19
IrelandStudy on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment
IrelandStudy Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer
IrelandThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on lung cancer treatments, including innovative therapies for non-small cell lung cancer and testing new drug combinations. Studies evaluating treatments for breast cancer, particularly in hormone receptor-positive and HER2-negative variants.
Multiple trials exploring combination therapies and novel treatment approaches for various cancer types.
Research initiatives examining treatments for chronic lymphocytic leukemia and lymphomas. Studies evaluating new therapeutic approaches for myelodysplastic syndromes, focusing on reducing transfusion dependency.
Innovative approaches combining multiple therapeutic agents to improve patient outcomes.
Clinical studies investigating treatments for Primary Sjögren's Disease and atopic dermatitis. Research on novel therapeutic approaches for inflammatory conditions and immune system disorders.
Focus on developing targeted therapies to improve patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
